Te Pātaka Whaioranga – Pharmac has confirmed it is widening access to ocrelizumab (branded as Ocrevus) as the first funded treatment for primary progressive multiple sclerosis
Te Whatu Ora - National Public Health Service is advising passengers from connecting flight OD195 from Perth to Auckland (arriving on Monday 28 August 2023) to monitor for whooping cough (pertussis) symptoms
The Government has today announced its commitment to roll out a national multi-agency approach to better respond to 111 calls for people experiencing mental distress
Source
Media Release from Minister of Health Ayesha Verrall and Minister of Police Ginny Anderson
Pharmac has missed a golden opportunity to allow more Kiwis access to a new breast cancer drug, a move that would have brought New Zealand into line with the rest of the world and removed a disparity that hits Māori and Pasifika hardest, says Breast Cancer Foundation NZ
Aotearoa is facing a critical shortage of culturally competent, qualified psychologists, which has placed pressure on the public, and current providers
Source
Joint Media Release from The NZ Psychological Society, NZ College of Clinical Psychologists and NZ Psychologists Board
The Urological Society of Australia and New Zealand (USANZ), the peak membership organisation for urological surgeons and other health professionals in the field of Urology supports New Zealand's decision to immediately pause mesh stress urinary incontinence (SUI) surgery in the best interests of patient safety
Source
Media Release from the Urological Society of Australia and New Zealand
Māori Primary Health Organisation’s (PHO’s) across Aotearoa are disappointed with the recently released Māori Health Advisory Committee Rapid Assessment, placing their support behind Te Aka Whai Ora as guiding the way forward for Māori health
Rare Disorders NZ is extremely frustrated that the Government is scrapping all remaining COVID-19 restrictions while Pharmac is still in the process of deciding whether to widen the access criteria for COVID-19 antivirals
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes